Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Ten years ago

Treatment of suicide attempters with bipolar disorder: a randomized clinical trial

October 18, 2021

Leo Sher, M.D.

Our research report, “Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior” was published in the October 2011 issue of the American Journal of Psychiatry (1). In our double-blind, randomized, parallel-group study, we tested the hypothesis that lithium offers bipolar patients with a history of suicide attempt greater protection against suicidal behavior compared to valproate.

To be included, patients had to have a DSM-IV diagnosis of a bipolar disorder (bipolar I or II disorder or bipolar disorder not otherwise specified) based on the Structured Clinical Interview for DSM-IV; be in a depressive or mixed episode; have at least one past suicide attempt; and be 18 to 75 years of age. Patients were randomly assigned to treatment with lithium or valproate, plus adjunctive medications as indicated, in a double-blind 2.5-year trial. We aimed to maintain patients on therapeutic dosages of lithium or valproate for the duration of the study. An intent-to-treat analysis was performed using the log-rank test for survival data. Two models were fitted: time to suicide attempt and time to suicide event (attempt or hospitalization or change in medication in response to suicide plans).

Average time in the study was not significantly different between the lithium and valproate groups. There were 45 suicide events in 35 participants, including 18 suicide attempts made by 14 participants, six from the lithium group and eight from the valproate group. There were no suicides. The event rate did not vary by sex. Intent-to-treat analysis using the log-rank test showed no differences between treatment groups in time to suicide attempt or to suicide event. Post hoc power calculations revealed that the modest sample size, reflective of challenges in recruitment, only permits detection of a relative risk of 5 or greater.

Contrary to our hypothesis, this randomized controlled trial revealed no difference in time to suicide attempt or suicide event between patients treated with lithium and those treated with valproate. The high rates of suicide attempts in both medication groups highlight the challenge of treating very suicidal patients.

Reference

  1. Oquendo MA, Galfalvy HC, Currier D, Grunebaum MF, Sher L, Sullivan GM, Burke AK, Harkavy-Friedman J, Sublette ME, Parsey RV, Mann JJ. Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. Am J Psychiatry. 2011 Oct;168(10):1050-6. doi: 10.1176/appi.ajp.2011.11010163. Epub 2011 Jul 18.

Related Posts

Ten years ago /

Teaching medical professionals and trainees about suicide prevention

Ten years ago /

Suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors

Ten years ago /

Posttraumatic stress disorder and the Neuroevolutionary Time-depth Principle

‹ Changes in suicide mortality during the COVID-19 pandemic › Clinical characteristics and psychiatric comorbidities in veterans with schizophrenia with or without suicidality

Editorials

  • Monkeypox: A psychiatrist’s guide
  • Fluvoxamine attenuates COVID-19 disease
  • What? Botox injections can mitigate depressions?
  • Smoking, suicide risk, and the COVID-19 pandemic

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Mortality rates for buprenorphine versus methadone treatments
  • Brain-derived neurotrophic factor levels in combat veterans with or without a history of suicide attempt
  • Pro-inflammatory cytokines and suicidality in patients with bipolar disorder
  • Thirty years of publications in the field of suicidology

Latest News

  • Leading world experts on suicide. Expertscape, the June 20, 2022, report
  • The U.S. Department of Veterans Affairs offers large prizes for suicide prevention ideas
  • Suicide mortality in the U.S. decreased from 2018 to 2020 after increasing since 2000
  • The World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Men’s Mental Health – January 2022 update

Interviews with eminent psychiatrists

  • Interview with Professor Shih-Ku Lin
  • Interview with Professor Masahito Fushimi
  • Interview with Professor Maurizio Pompili
  • Interview with Professor Marco Sarchiapone

Ten Years Ago

  • Teaching medical professionals and trainees about suicide prevention
  • Suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors
  • Treatment of suicide attempters with bipolar disorder: a randomized clinical trial
  • Posttraumatic stress disorder and the Neuroevolutionary Time-depth Principle

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2022 AVCalc LLC. All rights reserved worldwide.